Skip to main content

Breadcrumb

  1. Home

Full Year 2015

NCQA Supplemental items for CAHPS® 4.0 Adult Questionnaire (CAHPS 4.0H)

  • This supplemental set of items was developed jointly by NCQA and the AHRQ-sponsored CAHPS Consortium and is intended for use with the CAHPS 4.0 Health Plan survey. Some items are intended for Commercial health plan members only and are not included here. This measure provides information on the experiences of Medicaid health plan members with the organization. Results summarize member experiences through composites and question summary rates.

    CBE ID
    0007

Overutilization of Imaging Studies in Melanoma

  • Percentage of patients, regardless of age, with a current diagnosis of Stage 0 through IIC melanoma or a history of melanoma of any stage, without signs or symptoms suggesting systemic spread, seen for an office visit during the one-year measurement period, for whom no diagnostic imaging studies were ordered

    CBE ID
    0562

Patient Burn

  • Percentage of ASC admissions experiencing a burn prior to discharge

    CBE ID
    0263

Percent of Low Risk Residents Who Lose Control of Their Bowels or Bladder (Long-Stay)

  • This measure updates CMS’ MDS 2.0 QM on bowel and bladder control. It is based on data from Minimum Data Set (MDS) 3.0 assessments of low risk long-stay nursing facility residents (those whose cumulative days in the facility is greater than 100 days). This measure reports the percent of long-stay residents with a selected target assessment who are frequently or always bladder or bowel incontinent as indicated on the target MDS assessment (OBRA, PPS or discharge) during the selected quarter (3-month period).

    CBE ID
    0685

Percent of Residents Assessed and Appropriately Given the Pneumococcal Vaccine (Long-Stay)

  • This measure is based on data from MDS 3.0 assessments of long-stay nursing facility residents. The measure reports the percentage of all long-stay residents 5 years and older who were assessed and appropriately given the Pneumococcal Vaccination as reported on the target MDS assessment (OBRA, PPS or discharge) during the 12-month reporting period. This proposed measure is harmonized with NQF’s quality measure on Pneumococcal Immunizations.(1) The MDS 3.0 definitions have been changed to conform to the NQF standard.

    CBE ID
    0683